{"transactions":[{"id":786868,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":48727,"kind":"person","name":"Nark Ted C","position":1,"cik":"0001316851","reported_name":"Nark Ted C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-08T20:23:39.000Z","date":"2026-05-06","kind":"grant","planned":false,"acquired":true,"shares":19824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":19824,"derivative":{"underlying":"Class A Common Stock","underlying_shares":19824},"source":{"system":"sec-edgar","filing":"0001628280-26-032910","document":"wk-form4_1778271816.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026032910/wk-form4_1778271816.xml","form_type":"4"}},{"id":786867,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":48727,"kind":"person","name":"Nark Ted C","position":1,"cik":"0001316851","reported_name":"Nark Ted C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-08T20:23:39.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":false,"shares":34819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 6, 2025, the reporting person was granted 34,819 restricted stock units vesting on May 7, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 6, 2025, the reporting person was granted 34,819 restricted stock units vesting on May 7, 2026."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":34819},"source":{"system":"sec-edgar","filing":"0001628280-26-032910","document":"wk-form4_1778271816.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026032910/wk-form4_1778271816.xml","form_type":"4"}},{"id":786866,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":48727,"kind":"person","name":"Nark Ted C","position":1,"cik":"0001316851","reported_name":"Nark Ted C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-08T20:23:39.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":true,"shares":34819,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":325848,"source":{"system":"sec-edgar","filing":"0001628280-26-032910","document":"wk-form4_1778271816.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026032910/wk-form4_1778271816.xml","form_type":"4"}},{"id":993865,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":48727,"kind":"person","name":"Nark Ted C","position":1,"cik":"0001316851","reported_name":"Nark Ted C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-19T21:21:41.000Z","date":"2025-11-17","kind":"sale","planned":false,"acquired":false,"shares":50000,"price":11.72,"value":586000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.70 to $11.75 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":291029,"source":{"system":"sec-edgar","filing":"0001628280-25-053188","document":"wk-form4_1763587298.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025053188/wk-form4_1763587298.xml","form_type":"4"}},{"id":1155095,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":48727,"kind":"person","name":"Nark Ted C","position":1,"cik":"0001316851","reported_name":"Nark Ted C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-08T23:03:49.000Z","date":"2025-05-06","kind":"grant","planned":false,"acquired":true,"shares":34819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the\nfirst anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the\nfirst anniversary of the date of grant."}],"balance_after":34819,"derivative":{"underlying":"Class A Common Stock","underlying_shares":34819},"source":{"system":"sec-edgar","filing":"0001628280-25-023993","document":"wk-form4_1746745423.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025023993/wk-form4_1746745423.xml","form_type":"4"}},{"id":1155094,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":48727,"kind":"person","name":"Nark Ted C","position":1,"cik":"0001316851","reported_name":"Nark Ted C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-08T23:03:49.000Z","date":"2025-05-05","kind":"exercise","planned":false,"acquired":false,"shares":40258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 2, 2024, the reporting person was granted 40,258 restricted stock units vesting on May 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 2, 2024, the reporting person was granted 40,258 restricted stock units vesting on May 5, 2025."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":40258},"source":{"system":"sec-edgar","filing":"0001628280-25-023993","document":"wk-form4_1746745423.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025023993/wk-form4_1746745423.xml","form_type":"4"}},{"id":1155093,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":48727,"kind":"person","name":"Nark Ted C","position":1,"cik":"0001316851","reported_name":"Nark Ted C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-05-08T23:03:49.000Z","date":"2025-05-05","kind":"exercise","planned":false,"acquired":true,"shares":40258,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":341029,"source":{"system":"sec-edgar","filing":"0001628280-25-023993","document":"wk-form4_1746745423.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025023993/wk-form4_1746745423.xml","form_type":"4"}},{"id":1517592,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":48727,"kind":"person","name":"Nark Ted C","position":1,"cik":"0001316851","reported_name":"Nark Ted C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-14T20:40:36.000Z","date":"2024-05-10","kind":"exercise","planned":false,"acquired":false,"shares":76453,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 9, 2023 the reporting person was granted 76,453 restricted stock units vesting on May 10, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 9, 2023 the reporting person was granted 76,453 restricted stock units vesting on May 10, 2024."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":76453},"source":{"system":"sec-edgar","filing":"0001628280-24-023246","document":"wk-form4_1715719222.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024023246/wk-form4_1715719222.xml","form_type":"4"}},{"id":1517591,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":48727,"kind":"person","name":"Nark Ted C","position":1,"cik":"0001316851","reported_name":"Nark Ted C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-05-14T20:40:36.000Z","date":"2024-05-10","kind":"exercise","planned":false,"acquired":true,"shares":76453,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":300771,"source":{"system":"sec-edgar","filing":"0001628280-24-023246","document":"wk-form4_1715719222.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024023246/wk-form4_1715719222.xml","form_type":"4"}},{"id":1526380,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":48727,"kind":"person","name":"Nark Ted C","position":1,"cik":"0001316851","reported_name":"Nark Ted C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-06T21:34:14.000Z","date":"2024-05-02","kind":"grant","planned":false,"acquired":true,"shares":40258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":40258,"derivative":{"underlying":"Class A Common Stock","underlying_shares":40258},"source":{"system":"sec-edgar","filing":"0001628280-24-020740","document":"wk-form4_1715031240.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024020740/wk-form4_1715031240.xml","form_type":"4"}},{"id":1896757,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":48727,"kind":"person","name":"Nark Ted C","position":1,"cik":"0001316851","reported_name":"Nark Ted C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-11T20:15:14.000Z","date":"2023-05-10","kind":"exercise","planned":false,"acquired":false,"shares":80128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On May 9, 2022 the reporting person was granted 80,128 restricted stock units vesting on May 10, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On May 9, 2022 the reporting person was granted 80,128 restricted stock units vesting on May 10, 2023."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":80128},"source":{"system":"sec-edgar","filing":"0001209191-23-028731","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123028731/doc4.xml","form_type":"4"}},{"id":1896756,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":48727,"kind":"person","name":"Nark Ted C","position":1,"cik":"0001316851","reported_name":"Nark Ted C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-11T20:15:14.000Z","date":"2023-05-09","kind":"grant","planned":false,"acquired":true,"shares":76453,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":76453,"derivative":{"underlying":"Class A Common Stock","underlying_shares":76453},"source":{"system":"sec-edgar","filing":"0001209191-23-028731","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123028731/doc4.xml","form_type":"4"}},{"id":1896755,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":48727,"kind":"person","name":"Nark Ted C","position":1,"cik":"0001316851","reported_name":"Nark Ted C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-05-11T20:15:14.000Z","date":"2023-05-10","kind":"exercise","planned":false,"acquired":true,"shares":80128,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":224318,"source":{"system":"sec-edgar","filing":"0001209191-23-028731","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123028731/doc4.xml","form_type":"4"}},{"id":2276247,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":48727,"kind":"person","name":"Nark Ted C","position":1,"cik":"0001316851","reported_name":"Nark Ted C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-10T22:48:02.000Z","date":"2022-05-09","kind":"grant","acquired":true,"shares":80128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":80128,"derivative":{"underlying":"Class A Common Stock","underlying_shares":80128},"source":{"system":"sec-edgar","filing":"0001209191-22-028159","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122028159/doc4.xml","form_type":"4"}},{"id":2276246,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":48727,"kind":"person","name":"Nark Ted C","position":1,"cik":"0001316851","reported_name":"Nark Ted C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-10T22:48:02.000Z","date":"2022-05-08","kind":"exercise","acquired":false,"shares":35406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 5, 2021 the reporting person was granted 35,406 restricted stock units vesting on May 8, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 5, 2021 the reporting person was granted 35,406 restricted stock units vesting on May 8, 2022."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":35406},"source":{"system":"sec-edgar","filing":"0001209191-22-028159","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122028159/doc4.xml","form_type":"4"}},{"id":2276245,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":48727,"kind":"person","name":"Nark Ted C","position":1,"cik":"0001316851","reported_name":"Nark Ted C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-05-10T22:48:02.000Z","date":"2022-05-08","kind":"exercise","acquired":true,"shares":35406,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":144190,"source":{"system":"sec-edgar","filing":"0001209191-22-028159","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122028159/doc4.xml","form_type":"4"}},{"id":2723250,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":48727,"kind":"person","name":"Nark Ted C","position":1,"cik":"0001316851","reported_name":"Nark Ted C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-05-07T18:08:37.000Z","date":"2021-05-06","kind":"exercise","acquired":false,"shares":46218,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On May 5, 2020 the reporting person was granted 46,218 restricted stock units vesting on May 6, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On May 5, 2020 the reporting person was granted 46,218 restricted stock units vesting on May 6, 2021."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":46218},"source":{"system":"sec-edgar","filing":"0001209191-21-030812","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121030812/doc4.xml","form_type":"4"}},{"id":2723249,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":48727,"kind":"person","name":"Nark Ted C","position":1,"cik":"0001316851","reported_name":"Nark Ted C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-05-07T18:08:37.000Z","date":"2021-05-05","kind":"grant","acquired":true,"shares":35406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":35406,"derivative":{"underlying":"Class A Common Stock","underlying_shares":35406},"source":{"system":"sec-edgar","filing":"0001209191-21-030812","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121030812/doc4.xml","form_type":"4"}},{"id":2723248,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":48727,"kind":"person","name":"Nark Ted C","position":1,"cik":"0001316851","reported_name":"Nark Ted C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-05-07T18:08:37.000Z","date":"2021-05-06","kind":"exercise","acquired":true,"shares":46218,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":108784,"source":{"system":"sec-edgar","filing":"0001209191-21-030812","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121030812/doc4.xml","form_type":"4"}},{"id":3158176,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":48727,"kind":"person","name":"Nark Ted C","position":1,"cik":"0001316851","reported_name":"Nark Ted C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-05-07T21:25:24.000Z","date":"2020-05-07","kind":"exercise","acquired":false,"shares":6459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On May 6, 2019, the reporting person was granted 6,459 restricted stock units vesting on May 7, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On May 6, 2019, the reporting person was granted 6,459 restricted stock units vesting on May 7, 2020."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6459},"source":{"system":"sec-edgar","filing":"0000899243-20-012261","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924320012261/doc4.xml","form_type":"4"}},{"id":3158175,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":48727,"kind":"person","name":"Nark Ted C","position":1,"cik":"0001316851","reported_name":"Nark Ted C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-05-07T21:25:24.000Z","date":"2020-05-05","kind":"grant","acquired":true,"shares":46218,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":46218,"derivative":{"underlying":"Class A Common Stock","underlying_shares":46218},"source":{"system":"sec-edgar","filing":"0000899243-20-012261","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924320012261/doc4.xml","form_type":"4"}},{"id":3158174,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":48727,"kind":"person","name":"Nark Ted C","position":1,"cik":"0001316851","reported_name":"Nark Ted C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2020-05-07T21:25:24.000Z","date":"2020-05-07","kind":"exercise","acquired":true,"shares":6459,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":62566,"source":{"system":"sec-edgar","filing":"0000899243-20-012261","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924320012261/doc4.xml","form_type":"4"}},{"id":3427417,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":48727,"kind":"person","name":"Nark Ted C","position":1,"cik":"0001316851","reported_name":"Nark Ted C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2019-08-28T20:53:40.000Z","date":"2019-08-28","kind":"purchase","acquired":true,"shares":50000,"price":2.39,"value":119500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price.  These shares were acquired in multiple transactions at prices ranging from $2.38 per share to $2.44 per share.  The reporting person undertakes to provide Amneal Pharmaceuticals, Inc., any security holder of Amneal Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":56107,"source":{"system":"sec-edgar","filing":"0001723128-19-000120","document":"wf-form4_156702560470079.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000120/wf-form4_156702560470079.xml","form_type":"4"}},{"id":3535302,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":48727,"kind":"person","name":"Nark Ted C","position":1,"cik":"0001316851","reported_name":"Nark Ted C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-05-08T21:48:08.000Z","date":"2019-05-08","kind":"exercise","acquired":false,"shares":6107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On May 7, 2018, the reporting person was granted 6,107 restricted stock units vesting on May 8, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On May 7, 2018, the reporting person was granted 6,107 restricted stock units vesting on May 8, 2019."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6107},"source":{"system":"sec-edgar","filing":"0001723128-19-000070","document":"wf-form4_155735207281386.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000070/wf-form4_155735207281386.xml","form_type":"4"}},{"id":3535301,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":48727,"kind":"person","name":"Nark Ted C","position":1,"cik":"0001316851","reported_name":"Nark Ted C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-05-08T21:48:08.000Z","date":"2019-05-06","kind":"grant","acquired":true,"shares":6459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.  Restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.  Restricted stock units have no expiration date."}],"balance_after":6459,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6459},"source":{"system":"sec-edgar","filing":"0001723128-19-000070","document":"wf-form4_155735207281386.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000070/wf-form4_155735207281386.xml","form_type":"4"}},{"id":3535300,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":48727,"kind":"person","name":"Nark Ted C","position":1,"cik":"0001316851","reported_name":"Nark Ted C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-05-08T21:48:08.000Z","date":"2019-05-06","kind":"grant","acquired":true,"shares":28044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":28044,"derivative":{"exercise_price":14.05,"expiration_date":"2029-05-06","underlying":"Class A Common Stock","underlying_shares":28044},"source":{"system":"sec-edgar","filing":"0001723128-19-000070","document":"wf-form4_155735207281386.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000070/wf-form4_155735207281386.xml","form_type":"4"}},{"id":3535299,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":48727,"kind":"person","name":"Nark Ted C","position":1,"cik":"0001316851","reported_name":"Nark Ted C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2019-05-08T21:48:08.000Z","date":"2019-05-08","kind":"exercise","acquired":true,"shares":6107,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":6107,"source":{"system":"sec-edgar","filing":"0001723128-19-000070","document":"wf-form4_155735207281386.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000070/wf-form4_155735207281386.xml","form_type":"4"}},{"id":3941184,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":48727,"kind":"person","name":"Nark Ted C","position":1,"cik":"0001316851","reported_name":"Nark Ted C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-05-09T22:36:00.000Z","date":"2018-05-07","kind":"grant","acquired":true,"shares":6107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date."}],"balance_after":6107,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6107},"source":{"system":"sec-edgar","filing":"0000899243-18-012157","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318012157/doc4.xml","form_type":"4"}},{"id":3941183,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":48727,"kind":"person","name":"Nark Ted C","position":1,"cik":"0001316851","reported_name":"Nark Ted C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2018-05-09T22:36:00.000Z","date":"2018-05-07","kind":"grant","acquired":true,"shares":24977,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal annual installments beginning on May 07, 2019."}],"balance_after":24977,"derivative":{"exercise_price":15.01,"expiration_date":"2028-05-07","underlying":"Class A Common Stock","underlying_shares":24977},"source":{"system":"sec-edgar","filing":"0000899243-18-012157","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318012157/doc4.xml","form_type":"4"}}]}